Head and Neck Surgical Oncology
Head and neck cancer, Supportive care, Surgery
Research aim
To improve clinical practice by optimizing diagnosis, treatment and prognosis of head and neck cancer and related supportive care through interdisciplinary research
About us
The annual incidence of head and neck cancer in the Netherlands has risen from 2,000 to over 3,000 cases in 30 years, accounting for about 2.5% of all cancers. Despite this increase, it remains a rare disease. The most common types are cancers of the oral cavity (’23: 1,039), oropharynx (’23: 728), and larynx (’23: 623). Addressing the complexity of head and neck cancer requires a multifaceted approach. Our research focuses on advancing (early) detection and staging, improving (image guided) treatment and predictive and prognostic tools, decreasing morbidity, optimizing treatment decision-making, and enhancing survivorship and supportive care. We employ both qualitative and quantitative research methods to better understand the unique needs of these patients. Key priorities include disease control, survival, patient-reported outcomes, rehabilitation strategies, quality of life, and reducing long-term treatment side effects.
Collaboration is integral to our work, involving multidisciplinary teams across head and neck surgery, radiotherapy, medical oncology, and rehabilitation within UMC Utrecht. We also maintain strong partnerships with regional, national, and international research networks, enabling the translation of findings into clinical practice and ensuring meaningful impact for patients worldwide.